Latvia vs Lithuania: HICP - Tea, mate and other plant-derived products for infusion (ND)
Latvia
1.88
in 2026
Lithuania
1.89
in 2026
Latvia rank
4th
Lithuania rank
3rd
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Latvia
- Lithuania
How they compare
Lithuania currently reports 1.89 against 1.88 in Latvia, a difference of 0.01.
The two have swapped places 9 times across 31 shared years of data; in 1996 it was Latvia ahead.
Latvia ranks 4th and Lithuania ranks 3rd of 27 countries.
Across the 4 decades both report, Latvia averaged higher in 2 and Lithuania in 2.
Head to head by decade
| Decade | Latvia | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.77 | 1.8 | 0.9725 | Latvia |
| 2000s | 2.28 | 2.63 | 0.349 | Lithuania |
| 2010s | 1.78 | 2.15 | 0.365 | Lithuania |
| 2020s | 2.31 | 2.03 | 0.2786 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Latvia or Lithuania?
- Lithuania, at 1.89 against 1.88 in Latvia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Latvia and Lithuania?
- 0.01, with Lithuania ahead.
- How many years of comparable data are there for Latvia and Lithuania?
- 31 years are reported by both, from 1996 to 2026.
- How do Latvia and Lithuania rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Latvia ranks 4th and Lithuania ranks 3rd of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.